Home - Products - Neuroscience - Gamma-secretase - CIA-1 (Free base)

CIA-1 (Free base)

CAS No. 452087-38-6

CIA-1 (Free base)( —— )

Catalog No. M36369 CAS No. 452087-38-6

CIA-1 (Free base) is a nuclear receptor COUP-TFII inhibitor with IC50 values ranging from 1.2 μM to 7.6 μM in prostate cancer cell lines.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
2MG	79	Get Quote
5MG	117	Get Quote
10MG	187	Get Quote
25MG	364	Get Quote
50MG	569	Get Quote
100MG	858	Get Quote
500MG	Get Quote	Get Quote
1G	Get Quote	Get Quote

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

CIA-1 (Free base)
Note

Research use only, not for human use.
Brief Description

CIA-1 (Free base) is a nuclear receptor COUP-TFII inhibitor with IC50 values ranging from 1.2 μM to 7.6 μM in prostate cancer cell lines.
Description

CIA-1 (Free base) is a nuclear receptor COUP-TFII inhibitor with IC50 values ranging from 1.2 μM to 7.6 μM in prostate cancer cell lines. CIA-1 (Free base) inhibits tumor growth in a mouse model of prostate cancer xenografts.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

Neuroscience
Target

Gamma-secretase
Recptor

Gamma-secretase
Research Area

——
Indication

——

Chemical Information

CAS Number

452087-38-6
Formula Weight

329.42
Molecular Formula

C17H19N3O2S
Purity

>98% (HPLC)
Solubility

——
SMILES

N(CCC1=CC(OC)=C(OC)C=C1)C2=C3C(SC(C)=C3)=NC=N2
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

Enoticumab

Enoticumab (REGN421) is a fully human IgG1 monoclonal antibody with anticancer activity that inhibits the growth of cancer cells.Enoticumab binds human Dll4 and disrupts Notch-mediated signaling.
Compound W

The compound is an inhibitor of γ-secretase. It also causes a decrease in the released levels of Aβ42 and notch-1 Aβ-like peptide 25 (Nβ25).
PEAQX

PEAQX(NVP-AAM 077) is an effective and orally available NMDA antagonist. It can inhibit human NMDA receptors for 1A/2A(IC50: 270 nM), rather than 1A/2B(29, 600 nM).

Sign In Join Free